Significance of ramucirumab following atezolizumab plus bevacizumab therapy for hepatocellular carcinoma using real-world data.

Shigeo ShimoseRie SugimotoAtsushi HiraokaMasatoshi TanakaHideki IwamotoYuki TanakaFujimasa TadaHideko OhamaTakashi NiizekiTomotake ShironoEtsuko MoriyamaYu NodaNaoki KamachiMasahito NakanoRyoko KuromatsuHironori KogaTakumi Kawaguchi

Published in: Hepatology research : the official journal of the Japan Society of Hepatology (2022)

The therapeutic effect of RAM increased in patients with Atezo/Beva failure. Patients with splenomegaly and low BMI should be monitored for ascites during RAM treatment.

Keyphrases

body mass index
big data
cell free
weight gain
metastatic colorectal cancer
bone marrow
artificial intelligence